No Detail Found!

Chemotherapy combined with Shenmai injection alleviates inflammatory response and side efects in the patients with advanced colorectal cancer: A retrospective analysis

Author(s)
Yude Jin Department of General Surgery, The First Afiliated Hospital of Huzhou University 158,Guangchang Hou Road, Huzhou, Zhejiang Province,P.R. China
Wei Zhu Department of General Surgery, The First Afiliated Hospital of Huzhou University 158,Guangchang Hou Road, Huzhou, Zhejiang Province,P.R. China
Hanbin Dai Department of General Surgery, The First Afiliated Hospital of Huzhou University 158,Guangchang Hou Road, Huzhou, Zhejiang Province,P.R. China
Xiaowei He Department of General Surgery, The First Afiliated Hospital of Huzhou University 158,Guangchang Hou Road, Huzhou, Zhejiang Province,P.R. China
Abstract
Objective: To assess the inflammatory response and side efects of chemotherapy combined with Shenmai injection (SMI) in the treatment of patients with advanced colorectal cancer (CRC). Methods: This retrospective cohort study included the clinical data of 152 patients with advanced CRC admitted to the First Afiliated Hospital of Huzhou University from April 2020 to April 2023. The patients were divided into control group (patients received chemotherapy treatment, n=75) and observation group (patients received chemotherapy combined with SMI, n=77) based on the treatment received. Tumor control rate, levels of immune function indicators before and after treatment, levels of inflammatory factor indicators, and incidence of toxic side efects in two groups were analyzed. Results: Tumor control rate in the observation group (89.61%) was higher than that in the control group (77.33%) (P<0.05). After the treatment, the levels of CD3+, CD4+, CD4+/CD8+in both groups were significantly higher than before the treatment, and significantly higher in the observation group compared to the control group (P<0.05). After the treatment, serum levels of interleukin 6 (IL-6), tumor necrosis factor-alpha (TNF-a), and interleukin-8 (IL-8) in both groups decreased compared to pretreatment levels, and was significantly lower in the observation group (P<0.05). The incidence of adverse reactions in the observation group was significantly lower than that in the control group (P<0.05). Conclusions: Compared with chemotherapy alone, chemotherapy combined with SMI better alleviates inflammatory response in patients with advanced CRC, enhance immune function, and improve tumor control rate, with a lower incidence of toxic side efects.
Publication Details
Page(s) 1953-1957
Published Journal: Pakistan Journal of Medical Sciences, Volume: 40, Issue: 9, Year: 2024

Request the full text from PASTIC

Keywords
Immune function, colorectal cancer, chemotherapy, Shenmai injection
References
.2019 .Count in Colorectal Cancer. J Coll Physicians Surg Pak, 29(12) : 1173.
.2019 .. , 12 : .
. .A ten year retrospective study of 68 cases at Moffit Cancer Center. , : .
Sci Med .2020 .. , 10(2) : 1336-270.
. .ological and clinical characteristics of 52 cases with the colorectal serrated. , : .
Sci polyp. Pak J Med .2019 .. , 10(1) : 238-261.
.2022 .. , 10(1) : 144.
.2020 .. in Colorectal Cancer. Front Immunol, 10 : 369.
mu. .2020 .. , : .
.2021 .on molecular mechanisms. BMC Microbiol, 10(1) : 218.
. .. s12866-021-02274-3, : .
Prolif Cell .2020 .. , 10(10) : .
.2016 .. , 10(2) : 264-276.
Zhang S,Mi Y,Ye T,Lu X,Liu L,Qian J .2022 .Carbohydrates and ginsenosides in shenmai injection jointly improve hematopoietic function during chemotherapy-induced myelosuppression in mice. Chin Med, 10(1) : 124.
Qin GW,Xu TT,Lv XW,Jiang SM,Zhang KJ,Xu M .2021 .Efficacy and Safety of a Combination of Shenmai Injection plus Chemotherapy for the Treatment of Lung Cancer: A Meta-Analysis. Evid Based Complement Alternat Med, 10 : .
Wang L,Huang XE,Cao J. .2014 .Clinical study on safety of cantharidin sodium and shenmai injection combined with chemotherapy in treating patients with breast cancer postoperatively. Asian Pac J Cancer Prev, 15(14) : 5597-5600.
Zhang D,Zheng J,Ni M .2017 .Comparative efficacy and safety of Chinese herbal injections combined with the FOLFOX regimen for treating gastric cancer in China: a network meta-analysis. Oncotarget, 10(40) : 68873-68889.
Cubiella J,Marzo-Castillejo M,Mascort-Roca JJ,Amador-Romero FJ,Bellas-Beceiro B,Clofent-Vilaplana J .2018 .Clinical practice guideline. Diagnosis and prevention of colorectal cancer. 2018 Update. Gastroenterol Hepatol, 07(9) : 585-596.
Chalian H,Tore HG,Horowitz JM,Salem R,Miller FH,Yaghmai V,Radiographics V .2011 .Radiologic assessment of response to therapy: comparison of RECIST Versions 1. , 10(7) : 2093-2105.
Liu S,Zhang K,Hu X .2022 .Comparative efficacy and safety of Chinese medicine injections combined with capecitabine and oxaliplatin chemotherapies in treatment of colorectal cancer: A bayesian network meta-analysis. Front Pharmacol, 10 : 1004259.
Guo TH,Li YY,Hong SW,Cao QY,Chen H,Xu Y .2022 .. Evidence for Anticancer Effects of Chinese Medicine Monomers on Colorectal Cancer. Chin J Integr Med, 10(10) : 939-952.
Zhao H,He M,Zhang M,Sun Q,Zeng S,Chen L .2021 .Gut Microbiota and Traditional Chinese Medicine: A Systematic Review. Am J Chin Med, 10(4) : 805-828.
Cheng L,Liu W,Zhong C,Ni P,Ni S,Wang Q .2020 .Remodeling the homeostasis of pro- and anti-angiogenic factors by Shenmai injection to normalize tumor vasculature for enhanced cancer chemotherapy. J Ethnopharmacol, 10 : 113770.
Chen Y,Sun Y,Zhao Q,Liu C,Wang C .2021 .Shenmai injection enhances cisplatin-induced apoptosis through regulation of Mfn2-dependent mitochondrial dynamics in lung adenocarcinoma A549/DDP cells. Cancer Drug Resist, 10(4) : 1047-1060.
Zhong C,Jiang C,Ni S,Wang Q,Cheng L,Wang H .2019 .Identification of bioactive anti-angiogenic components targeting tumor endothelial cells in Shenmai injection using multidimensional pharmacokinetics. Acta Pharm Sin B, 12(9) : 1694-1708.
Qin GW,Xu TT,Lv XW,Jiang SM,Zhang KJ,Xu M .2021 .Efficacy and Safety of a Combination of Shenmai Injection plus Chemotherapy for the Treatment of Lung Cancer: A Meta-Analysis. Evid Based Complement Alternat Med, 10 : .
Kasprzak A .2021 .The Role of Tumor Microenvironment Cells in Colorectal Cancer (CRC) Cachexia. Int J Mol Sci, 10(4) : 1565.
Ben-Baruch A .2022 .Tumor Necrosis Factor α: Taking a Personalized Road in Cancer Therapy. Front Immunol, 10 : 903679.
Sun XJ,Feng TC,Wang YM,Wang F,Zhao JB,Liu X .2023 .The effect of the enhanced recovery after surgery protocol and the reduced use of opioids on postoperative outcomes in elderly patients with colorectal cancer. Eur Rev Med Pharmacol Sci, 10(20) : 34185-10060.
Bandara W,Muhinudeen F,Rathnayake A,Malaviarachchi S. .2023 .(10):e2477. World Cancer Res J, 10 : 2477.
Heichler C,Scheibe K,Schmied A,Geppert CI,Schmid B,Wirtz S .2020 .STAT3 activation through IL-6/IL-11 in cancer-associated fibroblasts promotes colorectal tumour development and correlates with poor prognosis. -319200, 10(7) : 1269-1282.
Casasanta MA,Yoo CC,Udayasuryan B,Sanders BE,Umana A,Zhang Y .2020 .Fusobacterium nucleatum host-cell binding and invasion induces IL-8 and CXCL1 secretion that drives colorectal cancer cell migration. Sci Signal, 10(641) : .
0

Citations

0

Downloads

76

Views